Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07221916 · ClinicalTrials.gov registry record

Stryker's Surgeon iD Mandible Reconstruction Plates: A Retrospective Post Market Follow Up

A clinical trial of Mandibular Reconstruction and Mandible Fracture, sponsored by Stryker Craniomaxillofacial.

Recruiting
Registry status
50
Enrollment target
2
Study locations

NCT07221916: Recruiting study of Mandibular Reconstruction and Mandible Fracture, sponsored by Stryker Craniomaxillofacial.

NCT07221916 is a study of Mandibular Reconstruction and Mandible Fracture that is actively recruiting participants, run by Stryker Craniomaxillofacial. The registered enrollment target is 50 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07221916, a study of Mandibular Reconstruction and Mandible Fracture, is actively recruiting participants, sponsored by Stryker Craniomaxillofacial.

RECRUITING
Registry status
50 participants
Enrollment target
2
Study locations

Study Summary

A retrospective post market follow up to confirm safety and performance of Stryker's Surgeon iD Plates (SMRP) medical device. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on its use.

Primary Outcome

Rate of unplanned revision surgery determined by reviewing adverse events in patient medical charts after surgery. Used to document whether an unplanned revision surgery was required or not for each patient.

Interventions

  • DEVICE Mandibular Reconstruction

Study Locations (2)

California

  • UCSF Otolaryngology Head and Neck Surgery - San Francisco

Other

  • Heinrich-Braun-Klinikum gGmbH - Zwickau

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-12-01
Est. Completion 2025-12-31
Stryker Craniomaxillofacial

5 total trials

What NCT07221916 shows while recruiting

NCT07221916 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.

The record links to 2 conditions, with Mandibular Reconstruction appearing as the primary indexed condition, and to 1 intervention - of which Mandibular Reconstruction is the first listed.

NCT07221916 reports a single indexed study location in California, Other.

Frequently Asked Questions

What is clinical trial NCT07221916 about?

NCT07221916 is a clinical study titled "Stryker's Surgeon iD Mandible Reconstruction Plates: A Retrospective Post Market Follow Up". A retrospective post market follow up to confirm safety and performance of Stryker's Surgeon iD Plates (SMRP) medical device. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on its use.

What is the current status of trial NCT07221916?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-12-01. Estimated completion is 2025-12-31.

What conditions does trial NCT07221916 study?

This clinical trial studies the following conditions: Mandibular Reconstruction, Mandible Fracture.

What interventions are being tested in trial NCT07221916?

The interventions under investigation include: Mandibular Reconstruction (DEVICE).

Who is sponsoring clinical trial NCT07221916?

This trial is sponsored by Stryker Craniomaxillofacial, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07221916 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mandibular Reconstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07221916, the US trial registry maintained by the National Library of Medicine. NCT07221916 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.